Generation Bio Co
Change company Symbol lookup
Select an option...
GBIO Generation Bio Co
UNP Union Pacific Corp
AHI Advanced Health Intelligence Ltd
EMUSF Electric Metals USA Ltd
INPX Inpixon
HUBC Hub Cyber Security Ltd
PTON Peloton Interactive Inc
PIXY ShiftPixy Inc
BCAN BYND Cannasoft Enterprises Inc
GLTO Galecto Inc

Health Care : Biotechnology | Small Cap Value
Company profile

Generation Bio Co. develops genetic medicines to provide treatments for rare and prevalent diseases. The Company through its non-viral genetic medicine platform, is engaged in developing genetic medicines to provide genetic payloads, which include large and multiple genes to a range of cell types across a range of diseases. Its platform is comprised of three component technologies: ceDNA, ctLNP and ceDNA manufacturing process. ceDNA is an engineered, double-stranded, linear, covalently closed-ended deoxyribonucleic acid (DNA) construct, which includes the gene of interest and associated regulatory sequences. It has produced ceDNA constructs of approximately eight kilobases. Its ctLNP delivery system builds upon clinically validated lipid nanoparticles and is designed to allow for repeat dosing of a genetic payload without stimulating an immune response, such as antibody production. Its ceDNA manufacturing process uses its own cell-free rapid enzymatic synthesis (RES) to produce ceDNA.

Closing Price
Day's Change
B/A Size
Day's High
Day's Low
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
  • Last (size)
  • 52-Wk Range
    -- - --
  • (-- - --)
  • 94.9%
  • Market Cap
  • Shares Outstanding
  • -2.08
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 84.76
  • (% of float 09/15/23)

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.